Supernus Pharmaceuticals (SUPN) Q1 2025 Earnings

25FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
0
0.39
0.78
1.17

Details

Expected EPS
0.52
Actual EPS
0.746403
Surprise EPS
0.23
Surprise Percent
+43.54%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.746403 per share for Q1 2025.

0 Comments

Share your thoughts